Biosimilar vitalizing Korea’s drug industry

Biosimilars are widely seen as a new engine of Korea’s economic growth. The drug company that pioneered its production now boasts of the largest market cap not only among pharmaceutical firms but also among the KOSDAQ-listed.

Leading pharmaceutical firms like Dong-A Pharmaceutical, Green Cross Corp. and Hanmi Pharmaceutical are jumping into the fray to sell drugs with similar properties to ...